Avecho Biotechnology experiences a significant revenue increase, reaching AU$1.13 million, marking a 139% growth. The company reports a net loss of AU$3.12 million, improving 9.2%
Category: Biotech
Revolutionizing Biotech: Dipal Doshi Joins Azenta’s Board of Directors
Dipal Doshi has been appointed to the Board of Directors at Azenta, Inc., marking a significant change in the company’s governance. His extensive experience in